BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31708785)

  • 1. Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics.
    Madamsetty VS; Mukherjee A; Mukherjee S
    Front Pharmacol; 2019; 10():1264. PubMed ID: 31708785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer.
    Mukherjee A; Madamsetty VS; Paul MK; Mukherjee S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F; Carugo D; Zhang X
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ synthesis of fluorescent polydopamine on biogenic MnO
    Liu J; Zhang M; Wu Y
    Biomater Sci; 2021 Sep; 9(17):5897-5906. PubMed ID: 34286709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anisotropic noble metal nanoparticles: Synthesis, surface functionalization and applications in biosensing, bioimaging, drug delivery and theranostics.
    Paramasivam G; Kayambu N; Rabel AM; Sundramoorthy AK; Sundaramurthy A
    Acta Biomater; 2017 Feb; 49():45-65. PubMed ID: 27915023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles.
    Jin KT; Yao JY; Ying XJ; Lin Y; Chen YF
    Curr Top Med Chem; 2020; 20(30):2737-2761. PubMed ID: 32962614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver Nanoparticles for Enhanced Cancer Theranostics:
    Li Y; Chang Y; Lian X; Zhou L; Yu Z; Wang H; An F
    J Biomed Nanotechnol; 2018 Sep; 14(9):1515-1542. PubMed ID: 29958548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advancements of Magnetic Nanomaterials in Cancer Therapy.
    Mukherjee S; Liang L; Veiseh O
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32053995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
    Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
    Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer theranostic applications of lipid-based nanoparticles.
    Tang WL; Tang WH; Li SD
    Drug Discov Today; 2018 May; 23(5):1159-1166. PubMed ID: 29660478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
    Vallabani NVS; Singh S; Karakoti AS
    Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
    Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
    Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable Inorganic Nanoparticles for Cancer Theranostics: Insights into the Degradation Behavior.
    Zhou H; Ge J; Miao Q; Zhu R; Wen L; Zeng J; Gao M
    Bioconjug Chem; 2020 Feb; 31(2):315-331. PubMed ID: 31765561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic nanoarchitectures for cancer sensing, imaging and therapy.
    KneŽević NŽ; Gadjanski I; Durand JO
    J Mater Chem B; 2019 Jan; 7(1):9-23. PubMed ID: 32254946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
    Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.
    Gou Y; Miao D; Zhou M; Wang L; Zhou H; Su G
    Front Pharmacol; 2018; 9():421. PubMed ID: 29755355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.